Market Access Sponsored NCVR: What's the true price of negotiation? A country’s ability to open trials quickly is a key consideration for commercial sponsors planning programmes of research globally.
Patients From participants to partners: The evolution of active patie... Recruitment numbers are the backbone of clinical research.
R&D Sponsored Revolutionising research: Inside the NCVR evolution in the U... On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
Patients Conducting successful commercial research in a primary care ... The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.
News Madrigal closes on EU approval of first MASH treatment Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face